If a patient is using hydroxychloroquine, then the average daily dose should be less than or equal to 5 mg/kg.
Submission Method: Registry
Methotrexate to Biologic Adherence to Treatment Pathway for Patients with Rheumatoid Arthritis
Percentage of patients aged 18 years or older with a diagnosis of RA AND receiving a first course therapy using a biologic disease-modifying antirheumatic drug (DMARD) who had a prescription for a conventional synthetic (cs) DMARD at least 10 weeks prior to newly initiated biologic therapy during the measurement year.
Patient Reported Outcome Physical Function Survey for Patients with Rheumatology Conditions
Percentage of patients aged 18 years and older with 2 or more rheumatology encounters with a documented diagnosis of rheumatoid arthritis (RA), psoriatic arthritis (PsA), or systemic lupus erythematosus (SLE) who have an assessment for physical function using ACR-preferred assessment tools or other tools deemed acceptable by the ACR at least once during the measurement year.
Avoiding the Prolonged Use of Moderate/High Dose Glucocorticoids for Patients with Systemic Lupus Erythematosus
Percentage of patients aged 18 years or older with a diagnosis of systemic lupus erythematosus (SLE), who are not prescribed an oral a glucocorticoid at a dose exceeding 5 mg per day prednisone equivalent for greater than 6 months.
Hydroxychloroquine Use in Patients with Systemic Lupus Erythematosus
Percentage of patients aged 18 years or older with a diagnosis of systemic lupus erythematosus (SLE), who have an active prescription for hydroxychloroquine during the measurement year.
Multi-strata weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan)
Weighted average of 3 former QCDR measures, ACRad 31, ACRad 32, ACRad 33.
Comprehensive Reporting of Coronary Artery Calcification (CAC) on Chest CT
Percentage of final reports for any chest CT examinations (non-cardiac, with or without contrast) performed on patients, aged 18 and older, that:
1. Document the presence or absence of coronary artery calcification (CAC),
2. If CAC is present, include documentation of a qualitative visual assessment of CAC and a recommendation that the patient consult with their primary care clinician for a comprehensive cardiovascular risk assessment, or a quantitative ordinal assessment of CAC for each of the four main coronary arteries. Recommendations for cardiovascular risk assessment should accompany any non-zero score.
Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism
Percentage of final reports for patients aged 18 years and older undergoing CT pulmonary angiography (CTPA) with a finding of PE that specify the branching order level of the most proximal level of embolus (i.e. main, lobar, interlobar, segmental, subsegmental); AND right ventricle to left ventricle (RV/LV) ratio, when assessable. If the RV/LV ratio is ?1.0, report the specific ratio value, as this may be associated with increased risk for adverse outcomes, and if the RV/LV ratio is <1.0, report that the ratio is within normal limits, optionally including a range (e.g., 0.7-0.9) to support clinical context.
Standardized Spine Fracture Classification Using Validated Systems
Percentage of final reports for patients with acute spinal fractures undergoing initial CT of the spine that include descriptive imaging findings.
Postoperative Ambulation
Percentage of patients ages 18 years and older, undergoing elective total hip and knee arthroplasty, who ambulated postoperatively on the day of surgery.